What is Bodd?
Bodd operates at the intersection of technology and human data, providing advanced 3D body scanning solutions. The company's core competency lies in the meticulous collection of detailed human body data, catering to a dual market of commercial applications and healthcare advancements. This strategic financing round signifies a critical juncture for Bodd, enabling it to scale its operations globally and enhance its technological offerings.
How much funding has Bodd raised?
Bodd has raised a total of $14.9M across 2 funding rounds:
Other Financing Round
$5M
Other Financing Round
$9.9M
Other Financing Round (2022): $5M with participation from Nick Hirons, Candace Hirons, and Tim Allison
Other Financing Round (2025): $9.9M led by Ellerston Capital and Blue Sky Capital
Key Investors in Bodd
Ellerston Capital
Ellerston Capital is an Australian investment management firm established in 2002, known for its innovative equity and alternative investment strategies across global markets, with a focus on the Oceania region.
Blue Sky Capital
Blue Sky Capital Corporation is a private investment firm that targets high-potential teams and technologies, particularly in mobile and security for the financial services sector, emphasizing long-term growth and rapid response to opportunities.
Nick Hirons
Undisclosed investor participating in the funding round.
What's next for Bodd?
With the recent influx of capital, Bodd is strategically positioned for significant growth. The company's focus on international expansion suggests an ambition to capture new markets and establish a broader global footprint. Concurrently, investment in product development indicates a commitment to refining and innovating its 3D body scanning technology, potentially leading to new applications and enhanced data accuracy for its commercial and healthcare clients. This enterprise-level backing signals strong investor confidence in Bodd's business model and future potential.
See full Bodd company page
